Products mRNA vaccines are commercially available as injectables. The first in this group to be approved in many countries was BNT162b2 from BioNTech and Pfizer on December 19, 2020. Moderna’s mRNA-1273 is also an mRNA vaccine. It was released in the EU on January 6, 2021. Both are covid-19 vaccines. Structure and properties mRNA (short … MRNA Vaccines
Products Follitropin beta is commercially available as a solution for injection (Puregon). It has been approved in many countries since 2001. Structure and properties Follitropin beta is a recombinant human follicle-stimulating hormone (FSH) produced by biotechnological methods. The amino acid sequence corresponds to human FSH. It differs from follitropin alfa in glycosylation. FSH is a … Follitropin Beta
Products Interferon beta-1a is commercially available as a solution for injection (Avonex, Rebif). It has been approved in many countries since 1997. Structure and properties Interferon beta-1a is a recombinant protein biotechnologically derived from CHO cells. It consists of 166 amino acids, has the same amino acid sequence as natural interferon beta, and is glycosylated … Interferon Beta-1A
Products Sebelipase alfa was approved in the EU and US in 2015 and in many countries in 2016 as a concentrate for the preparation of an infusion solution (Kanuma). Structure and properties Sebelipase alfa is a recombinant human lysosomal acid lipase (rhLAL) with the same amino acid sequence as the endogenous enzyme. The protein is … Sebelipase Alfa
Products Biosimilars are copycat preparations of biotechnology-derived drugs (biologics) that have strong similarities to the originator drugs but that are not exactly the same. The similarity relates to biological activity, structure, function, purity and safety, among other things. Biosimilars differ from generics of small molecule drugs in important ways. Biosimilars are usually marketed as injection … Biosimilars
